M&T Bank
ANAC

M&T Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

M&T Bank’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,696
Closed -$434K – 1923
2015
Q3 		$434K Buy
3,696
+642
+21% +$83.8K ﹤0.01% 1128
2015
Q2 		$236K Buy
+3,054
New +$200K ﹤0.01% 1660

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

M&T Bank's ANAC Position: Q4 2015 in Review

M&T Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 3,696 shares — an estimated $434K sold.

M&T Bank first reported a position in ANAC in Q2 2015 and held it in 2 quarters. The position peaked at $434K in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • M&T Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • M&T Bank sold 3,696 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $434K.
  • M&T Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 2 quarters.
  • M&T Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $434K in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on M&T Bank's 13F filing for Q4 2015, filed 12 Feb 2016.